1 Market Overview

1.1 Product Overview and Scope of Pharmaceuticals and Biotechnology R&D

1.2 Classification of Pharmaceuticals and Biotechnology R&D by Type

1.2.1 Overview: Global Pharmaceuticals and Biotechnology R&D Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Type in 2020

1.2.3 Drug

1.2.4 Medical Equipment

1.2.5 Vaccine

1.2.6 Others

1.3 Global Pharmaceuticals and Biotechnology R&D Market by Application

1.3.1 Overview: Global Pharmaceuticals and Biotechnology R&D Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Homecare

1.3.5 Others

1.4 Global Pharmaceuticals and Biotechnology R&D Market Size & Forecast

1.5 Global Pharmaceuticals and Biotechnology R&D Market Size and Forecast by Region

1.5.1 Global Pharmaceuticals and Biotechnology R&D Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Pharmaceuticals and Biotechnology R&D Market Size by Region, (2016-2021)

1.5.3 North America Pharmaceuticals and Biotechnology R&D Market Size and Prospect (2016-2026)

1.5.4 Europe Pharmaceuticals and Biotechnology R&D Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size and Prospect (2016-2026)

1.5.6 South America Pharmaceuticals and Biotechnology R&D Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Pharmaceuticals and Biotechnology R&D Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Pharmaceuticals and Biotechnology R&D Market Drivers

1.6.2 Pharmaceuticals and Biotechnology R&D Market Restraints

1.6.3 Pharmaceuticals and Biotechnology R&D Trends Analysis

2 Company Profiles

2.1 ROCHE

2.1.1 ROCHE Details

2.1.2 ROCHE Major Business

2.1.3 ROCHE Pharmaceuticals and Biotechnology R&D Product and Solutions

2.1.4 ROCHE Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 ROCHE Recent Developments and Future Plans

2.2 JOHNSON & JOHNSON

2.2.1 JOHNSON & JOHNSON Details

2.2.2 JOHNSON & JOHNSON Major Business

2.2.3 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Product and Solutions

2.2.4 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 JOHNSON & JOHNSON Recent Developments and Future Plans

2.3 MERCK

2.3.1 MERCK Details

2.3.2 MERCK Major Business

2.3.3 MERCK Pharmaceuticals and Biotechnology R&D Product and Solutions

2.3.4 MERCK Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 MERCK Recent Developments and Future Plans

2.4 NOVARTIS

2.4.1 NOVARTIS Details

2.4.2 NOVARTIS Major Business

2.4.3 NOVARTIS Pharmaceuticals and Biotechnology R&D Product and Solutions

2.4.4 NOVARTIS Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 NOVARTIS Recent Developments and Future Plans

2.5 PFIZER

2.5.1 PFIZER Details

2.5.2 PFIZER Major Business

2.5.3 PFIZER Pharmaceuticals and Biotechnology R&D Product and Solutions

2.5.4 PFIZER Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 PFIZER Recent Developments and Future Plans

2.6 SANOFI

2.6.1 SANOFI Details

2.6.2 SANOFI Major Business

2.6.3 SANOFI Pharmaceuticals and Biotechnology R&D Product and Solutions

2.6.4 SANOFI Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 SANOFI Recent Developments and Future Plans

2.7 BAYER

2.7.1 BAYER Details

2.7.2 BAYER Major Business

2.7.3 BAYER Pharmaceuticals and Biotechnology R&D Product and Solutions

2.7.4 BAYER Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 BAYER Recent Developments and Future Plans

2.8 BRISTOL-MYERS SQUIBB

2.8.1 BRISTOL-MYERS SQUIBB Details

2.8.2 BRISTOL-MYERS SQUIBB Major Business

2.8.3 BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Product and Solutions

2.8.4 BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 BRISTOL-MYERS SQUIBB Recent Developments and Future Plans

2.9 ASTRAZENECA

2.9.1 ASTRAZENECA Details

2.9.2 ASTRAZENECA Major Business

2.9.3 ASTRAZENECA Pharmaceuticals and Biotechnology R&D Product and Solutions

2.9.4 ASTRAZENECA Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 ASTRAZENECA Recent Developments and Future Plans

2.10 GLAXOSMITHKLINE

2.10.1 GLAXOSMITHKLINE Details

2.10.2 GLAXOSMITHKLINE Major Business

2.10.3 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Product and Solutions

2.10.4 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 GLAXOSMITHKLINE Recent Developments and Future Plans

2.11 ABBVIE

2.11.1 ABBVIE Details

2.11.2 ABBVIE Major Business

2.11.3 ABBVIE Pharmaceuticals and Biotechnology R&D Product and Solutions

2.11.4 ABBVIE Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 ABBVIE Recent Developments and Future Plans

2.12 ELI LILLY

2.12.1 ELI LILLY Details

2.12.2 ELI LILLY Major Business

2.12.3 ELI LILLY Pharmaceuticals and Biotechnology R&D Product and Solutions

2.12.4 ELI LILLY Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 ELI LILLY Recent Developments and Future Plans

2.13 BOEHRINGER SOHN

2.13.1 BOEHRINGER SOHN Details

2.13.2 BOEHRINGER SOHN Major Business

2.13.3 BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Product and Solutions

2.13.4 BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 BOEHRINGER SOHN Recent Developments and Future Plans

2.14 AMGEN

2.14.1 AMGEN Details

2.14.2 AMGEN Major Business

2.14.3 AMGEN Pharmaceuticals and Biotechnology R&D Product and Solutions

2.14.4 AMGEN Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 AMGEN Recent Developments and Future Plans

2.15 GILEAD SCIENCES

2.15.1 GILEAD SCIENCES Details

2.15.2 GILEAD SCIENCES Major Business

2.15.3 GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Product and Solutions

2.15.4 GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 GILEAD SCIENCES Recent Developments and Future Plans

2.16 TAKEDA PHARMACEUTICAL

2.16.1 TAKEDA PHARMACEUTICAL Details

2.16.2 TAKEDA PHARMACEUTICAL Major Business

2.16.3 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Product and Solutions

2.16.4 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 TAKEDA PHARMACEUTICAL Recent Developments and Future Plans

2.17 NOVO NORDISK

2.17.1 NOVO NORDISK Details

2.17.2 NOVO NORDISK Major Business

2.17.3 NOVO NORDISK Pharmaceuticals and Biotechnology R&D Product and Solutions

2.17.4 NOVO NORDISK Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 NOVO NORDISK Recent Developments and Future Plans

2.18 BIOGEN

2.18.1 BIOGEN Details

2.18.2 BIOGEN Major Business

2.18.3 BIOGEN Pharmaceuticals and Biotechnology R&D Product and Solutions

2.18.4 BIOGEN Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 BIOGEN Recent Developments and Future Plans

2.19 ABBOTT

2.19.1 ABBOTT Details

2.19.2 ABBOTT Major Business

2.19.3 ABBOTT Pharmaceuticals and Biotechnology R&D Product and Solutions

2.19.4 ABBOTT Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.19.5 ABBOTT Recent Developments and Future Plans

2.20 ASTELLAS PHARMA

2.20.1 ASTELLAS PHARMA Details

2.20.2 ASTELLAS PHARMA Major Business

2.20.3 ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Product and Solutions

2.20.4 ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.20.5 ASTELLAS PHARMA Recent Developments and Future Plans

2.21 TEVA PHARMACEUTICAL INDUSTRIES

2.21.1 TEVA PHARMACEUTICAL INDUSTRIES Details

2.21.2 TEVA PHARMACEUTICAL INDUSTRIES Major Business

2.21.3 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Product and Solutions

2.21.4 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Revenue, Gross Margin and Market Share (2019-2021)

2.21.5 TEVA PHARMACEUTICAL INDUSTRIES Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Pharmaceuticals and Biotechnology R&D Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Pharmaceuticals and Biotechnology R&D Players Market Share

3.2.2 Top 10 Pharmaceuticals and Biotechnology R&D Players Market Share

3.2.3 Market Competition Trend

3.3 Pharmaceuticals and Biotechnology R&D Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Pharmaceuticals and Biotechnology R&D Revenue and Market Share by Type (2016-2021)

4.2 Global Pharmaceuticals and Biotechnology R&D Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Application (2016-2021)

5.2 Pharmaceuticals and Biotechnology R&D Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Pharmaceuticals and Biotechnology R&D Revenue by Type (2016-2026)

6.2 North America Pharmaceuticals and Biotechnology R&D Revenue by Application (2016-2026)

6.3 North America Pharmaceuticals and Biotechnology R&D Market Size by Country

6.3.1 North America Pharmaceuticals and Biotechnology R&D Revenue by Country (2016-2026)

6.3.2 United States Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

6.3.3 Canada Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

6.3.4 Mexico Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Pharmaceuticals and Biotechnology R&D Revenue by Type (2016-2026)

7.2 Europe Pharmaceuticals and Biotechnology R&D Revenue by Application (2016-2026)

7.3 Europe Pharmaceuticals and Biotechnology R&D Market Size by Country

7.3.1 Europe Pharmaceuticals and Biotechnology R&D Revenue by Country (2016-2026)

7.3.2 Germany Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

7.3.3 France Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

7.3.5 Russia Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

7.3.6 Italy Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Type (2016-2026)

8.2 Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Application (2016-2026)

8.3 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Region

8.3.1 Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Region (2016-2026)

8.3.2 China Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

8.3.3 Japan Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

8.3.4 South Korea Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

8.3.5 India Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

8.3.7 Australia Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Pharmaceuticals and Biotechnology R&D Revenue by Type (2016-2026)

9.2 South America Pharmaceuticals and Biotechnology R&D Revenue by Application (2016-2026)

9.3 South America Pharmaceuticals and Biotechnology R&D Market Size by Country

9.3.1 South America Pharmaceuticals and Biotechnology R&D Revenue by Country (2016-2026)

9.3.2 Brazil Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

9.3.3 Argentina Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Type (2016-2026)

10.2 Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Application (2016-2026)

10.3 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Country

10.3.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Country (2016-2026)

10.3.2 Turkey Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

10.3.4 UAE Pharmaceuticals and Biotechnology R&D Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Pharmaceuticals and Biotechnology R&D Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Pharmaceuticals and Biotechnology R&D Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Pharmaceuticals and Biotechnology R&D Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Pharmaceuticals and Biotechnology R&D Revenue (USD Million) by Region (2016-2021)

Table 5. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Region (2021-2026)

Table 6. ROCHE Corporate Information, Head Office, and Major Competitors

Table 7. ROCHE Major Business

Table 8. ROCHE Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 9. ROCHE Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. JOHNSON & JOHNSON Corporate Information, Head Office, and Major Competitors

Table 11. JOHNSON & JOHNSON Major Business

Table 12. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 13. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. MERCK Corporate Information, Head Office, and Major Competitors

Table 15. MERCK Major Business

Table 16. MERCK Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 17. MERCK Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. NOVARTIS Corporate Information, Head Office, and Major Competitors

Table 19. NOVARTIS Major Business

Table 20. NOVARTIS Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 21. NOVARTIS Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. PFIZER Corporate Information, Head Office, and Major Competitors

Table 23. PFIZER Major Business

Table 24. PFIZER Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 25. PFIZER Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. SANOFI Corporate Information, Head Office, and Major Competitors

Table 27. SANOFI Major Business

Table 28. SANOFI Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 29. SANOFI Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. BAYER Corporate Information, Head Office, and Major Competitors

Table 31. BAYER Major Business

Table 32. BAYER Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 33. BAYER Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. BRISTOL-MYERS SQUIBB Corporate Information, Head Office, and Major Competitors

Table 35. BRISTOL-MYERS SQUIBB Major Business

Table 36. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 37. BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. ASTRAZENECA Corporate Information, Head Office, and Major Competitors

Table 39. ASTRAZENECA Major Business

Table 40. ASTRAZENECA Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 41. ASTRAZENECA Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. GLAXOSMITHKLINE Corporate Information, Head Office, and Major Competitors

Table 43. GLAXOSMITHKLINE Major Business

Table 44. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 45. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. ABBVIE Corporate Information, Head Office, and Major Competitors

Table 47. ABBVIE Major Business

Table 48. ABBVIE Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 49. ABBVIE Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. ELI LILLY Corporate Information, Head Office, and Major Competitors

Table 51. ELI LILLY Major Business

Table 52. ELI LILLY Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 53. ELI LILLY Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. BOEHRINGER SOHN Corporate Information, Head Office, and Major Competitors

Table 55. BOEHRINGER SOHN Major Business

Table 56. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 57. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. AMGEN Corporate Information, Head Office, and Major Competitors

Table 59. AMGEN Major Business

Table 60. AMGEN Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 61. AMGEN Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. GILEAD SCIENCES Corporate Information, Head Office, and Major Competitors

Table 63. GILEAD SCIENCES Major Business

Table 64. GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 65. GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. TAKEDA PHARMACEUTICAL Corporate Information, Head Office, and Major Competitors

Table 67. TAKEDA PHARMACEUTICAL Major Business

Table 68. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 69. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. NOVO NORDISK Corporate Information, Head Office, and Major Competitors

Table 71. NOVO NORDISK Major Business

Table 72. NOVO NORDISK Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 73. NOVO NORDISK Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. BIOGEN Corporate Information, Head Office, and Major Competitors

Table 75. BIOGEN Major Business

Table 76. BIOGEN Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 77. BIOGEN Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. ABBOTT Corporate Information, Head Office, and Major Competitors

Table 79. ABBOTT Major Business

Table 80. ABBOTT Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 81. ABBOTT Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 82. ASTELLAS PHARMA Corporate Information, Head Office, and Major Competitors

Table 83. ASTELLAS PHARMA Major Business

Table 84. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 85. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 86. TEVA PHARMACEUTICAL INDUSTRIES Corporate Information, Head Office, and Major Competitors

Table 87. TEVA PHARMACEUTICAL INDUSTRIES Major Business

Table 88. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Product and Solutions

Table 89. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 90. Global Pharmaceuticals and Biotechnology R&D Revenue (USD Million) by Players (2019-2021)

Table 91. Global Pharmaceuticals and Biotechnology R&D Revenue Share by Players (2019-2021)

Table 92. Breakdown of Pharmaceuticals and Biotechnology R&D by Company Type (Tier 1, Tier 2 and Tier 3)

Table 93. Pharmaceuticals and Biotechnology R&D Players Head Office, Products and Services Provided

Table 94. Pharmaceuticals and Biotechnology R&D Mergers & Acquisitions in the Past Five Years

Table 95. Pharmaceuticals and Biotechnology R&D New Entrants and Expansion Plans

Table 96. Global Pharmaceuticals and Biotechnology R&D Revenue (USD Million) by Type (2016-2021)

Table 97. Global Pharmaceuticals and Biotechnology R&D Revenue Share by Type (2016-2021)

Table 98. Global Pharmaceuticals and Biotechnology R&D Revenue Forecast by Type (2021-2026)

Table 99. Global Pharmaceuticals and Biotechnology R&D Revenue by Application (2016-2021)

Table 100. Global Pharmaceuticals and Biotechnology R&D Revenue Forecast by Application (2021-2026)

Table 101. North America Pharmaceuticals and Biotechnology R&D Revenue by Type (2016-2021) & (USD Million)

Table 102. North America Pharmaceuticals and Biotechnology R&D Revenue by Type (2021-2026) & (USD Million)

Table 103. North America Pharmaceuticals and Biotechnology R&D Revenue by Application (2016-2021) & (USD Million)

Table 104. North America Pharmaceuticals and Biotechnology R&D Revenue by Application (2021-2026) & (USD Million)

Table 105. North America Pharmaceuticals and Biotechnology R&D Revenue by Country (2016-2021) & (USD Million)

Table 106. North America Pharmaceuticals and Biotechnology R&D Revenue by Country (2021-2026) & (USD Million)

Table 107. Europe Pharmaceuticals and Biotechnology R&D Revenue by Type (2016-2021) & (USD Million)

Table 108. Europe Pharmaceuticals and Biotechnology R&D Revenue by Type (2021-2026) & (USD Million)

Table 109. Europe Pharmaceuticals and Biotechnology R&D Revenue by Application (2016-2021) & (USD Million)

Table 110. Europe Pharmaceuticals and Biotechnology R&D Revenue by Application (2021-2026) & (USD Million)

Table 111. Europe Pharmaceuticals and Biotechnology R&D Revenue by Country (2016-2021) & (USD Million)

Table 112. Europe Pharmaceuticals and Biotechnology R&D Revenue by Country (2021-2026) & (USD Million)

Table 113. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Type (2016-2021) & (USD Million)

Table 114. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Type (2021-2026) & (USD Million)

Table 115. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Application (2016-2021) & (USD Million)

Table 116. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Application (2021-2026) & (USD Million)

Table 117. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Region (2016-2021) & (USD Million)

Table 118. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue by Region (2021-2026) & (USD Million)

Table 119. South America Pharmaceuticals and Biotechnology R&D Revenue by Type (2016-2021) & (USD Million)

Table 120. South America Pharmaceuticals and Biotechnology R&D Revenue by Type (2021-2026) & (USD Million)

Table 121. South America Pharmaceuticals and Biotechnology R&D Revenue by Application (2016-2021) & (USD Million)

Table 122. South America Pharmaceuticals and Biotechnology R&D Revenue by Application (2021-2026) & (USD Million)

Table 123. South America Pharmaceuticals and Biotechnology R&D Revenue by Country (2016-2021) & (USD Million)

Table 124. South America Pharmaceuticals and Biotechnology R&D Revenue by Country (2021-2026) & (USD Million)

Table 125. Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Type (2016-2021) & (USD Million)

Table 126. Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Type (2021-2026) & (USD Million)

Table 127. Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Application (2016-2021) & (USD Million)

Table 128. Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Application (2021-2026) & (USD Million)

Table 129. Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Country (2016-2021) & (USD Million)

Table 130. Middle East & Africa Pharmaceuticals and Biotechnology R&D Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Pharmaceuticals and Biotechnology R&D Picture

Figure 2. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Type in 2020

Figure 3. Drug

Figure 4. Medical Equipment

Figure 5. Vaccine

Figure 6. Others

Figure 7. Pharmaceuticals and Biotechnology R&D Revenue Market Share by Application in 2020

Figure 8. Hospital Picture

Figure 9. Clinic Picture

Figure 10. Homecare Picture

Figure 11. Others Picture

Figure 12. Global Pharmaceuticals and Biotechnology R&D Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Pharmaceuticals and Biotechnology R&D Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Region (2016-2026)

Figure 15. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Region in 2020

Figure 16. North America Pharmaceuticals and Biotechnology R&D Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Pharmaceuticals and Biotechnology R&D Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Pharmaceuticals and Biotechnology R&D Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Pharmaceuticals and Biotechnology R&D Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Pharmaceuticals and Biotechnology R&D Market Drivers

Figure 22. Pharmaceuticals and Biotechnology R&D Market Restraints

Figure 23. Pharmaceuticals and Biotechnology R&D Market Trends

Figure 24. ROCHE Recent Developments and Future Plans

Figure 25. JOHNSON & JOHNSON Recent Developments and Future Plans

Figure 26. MERCK Recent Developments and Future Plans

Figure 27. NOVARTIS Recent Developments and Future Plans

Figure 28. PFIZER Recent Developments and Future Plans

Figure 29. SANOFI Recent Developments and Future Plans

Figure 30. BAYER Recent Developments and Future Plans

Figure 31. BRISTOL-MYERS SQUIBB Recent Developments and Future Plans

Figure 32. ASTRAZENECA Recent Developments and Future Plans

Figure 33. GLAXOSMITHKLINE Recent Developments and Future Plans

Figure 34. ABBVIE Recent Developments and Future Plans

Figure 35. ELI LILLY Recent Developments and Future Plans

Figure 36. BOEHRINGER SOHN Recent Developments and Future Plans

Figure 37. AMGEN Recent Developments and Future Plans

Figure 38. GILEAD SCIENCES Recent Developments and Future Plans

Figure 39. TAKEDA PHARMACEUTICAL Recent Developments and Future Plans

Figure 40. NOVO NORDISK Recent Developments and Future Plans

Figure 41. BIOGEN Recent Developments and Future Plans

Figure 42. ABBOTT Recent Developments and Future Plans

Figure 43. ASTELLAS PHARMA Recent Developments and Future Plans

Figure 44. TEVA PHARMACEUTICAL INDUSTRIES Recent Developments and Future Plans

Figure 45. Global Pharmaceuticals and Biotechnology R&D Revenue Share by Players in 2020

Figure 46. Pharmaceuticals and Biotechnology R&D Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 47. Global Top 3 Players Pharmaceuticals and Biotechnology R&D Revenue Market Share in 2020

Figure 48. Global Top 10 Players Pharmaceuticals and Biotechnology R&D Revenue Market Share in 2020

Figure 49. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 50. Global Pharmaceuticals and Biotechnology R&D Revenue Share by Type in 2020

Figure 51. Global Pharmaceuticals and Biotechnology R&D Market Share Forecast by Type (2021-2026)

Figure 52. Global Pharmaceuticals and Biotechnology R&D Revenue Share by Application in 2020

Figure 53. Global Pharmaceuticals and Biotechnology R&D Market Share Forecast by Application (2021-2026)

Figure 54. North America Pharmaceuticals and Biotechnology R&D Sales Market Share by Type (2016-2026)

Figure 55. North America Pharmaceuticals and Biotechnology R&D Sales Market Share by Application (2016-2026)

Figure 56. North America Pharmaceuticals and Biotechnology R&D Revenue Market Share by Country (2016-2026)

Figure 57. United States Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Canada Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Mexico Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Europe Pharmaceuticals and Biotechnology R&D Sales Market Share by Type (2016-2026)

Figure 61. Europe Pharmaceuticals and Biotechnology R&D Sales Market Share by Application (2016-2026)

Figure 62. Europe Pharmaceuticals and Biotechnology R&D Revenue Market Share by Country (2016-2026)

Figure 63. Germany Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. France Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. United Kingdom Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Russia Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Italy Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Asia-Pacific Pharmaceuticals and Biotechnology R&D Sales Market Share by Type (2016-2026)

Figure 69. Asia-Pacific Pharmaceuticals and Biotechnology R&D Sales Market Share by Application (2016-2026)

Figure 70. Asia-Pacific Pharmaceuticals and Biotechnology R&D Revenue Market Share by Region (2016-2026)

Figure 71. China Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Japan Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. South Korea Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. India Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Southeast Asia Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Australia Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. South America Pharmaceuticals and Biotechnology R&D Sales Market Share by Type (2016-2026)

Figure 78. South America Pharmaceuticals and Biotechnology R&D Sales Market Share by Application (2016-2026)

Figure 79. South America Pharmaceuticals and Biotechnology R&D Revenue Market Share by Country (2016-2026)

Figure 80. Brazil Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 81. Argentina Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 82. Middle East and Africa Pharmaceuticals and Biotechnology R&D Sales Market Share by Type (2016-2026)

Figure 83. Middle East and Africa Pharmaceuticals and Biotechnology R&D Sales Market Share by Application (2016-2026)

Figure 84. Middle East and Africa Pharmaceuticals and Biotechnology R&D Revenue Market Share by Country (2016-2026)

Figure 85. Turkey Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 86. Saudi Arabia Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 87. UAE Pharmaceuticals and Biotechnology R&D Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 88. Methodology

Figure 89. Research Process and Data Source